ArticleRSC medicinal chemistry2024

Discovery of first-in-class PROTACs targeting maternal embryonic leucine zipper kinase (MELK) for the treatment of Burkitt lymphoma.

Yonghui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.